... 2018, also Globenewswire.com with their article: “Generex Biotechnology Announces that its Subsidiary Olaregen ... (SAWC) in San Antonio, TX – GlobeNewswire” published on May 16, 2019, Midasletter.com published: “Cannex ...
News
- ANTHERA PHARMACEUTICALS INC (OTCMKTS:ANTH) on Focus After Report of Less Shorts
- Julie Champine, MD, Radiologist / Professor of Radiology at UT Southwestern Medical Center
Its three-part mission is to educate leaders in patient care, biomedical ... from the University of Texas Health Science Center at San Antonio in 1988.
- Coherus Biosciences (CHRS) Holder Platinum Investment Management LTD Has Trimmed Its ...
Coherus Biosciences (CHRS) Holder Platinum Investment Management LTD ... 21/05/2018 – Baptist Emergency Hospitals In San Antonio Again Receive ... Coherus BioSciences, Inc. (NASDAQ:CHRS) has risen 2.63% since June ...
- Initial public offerings scheduled to debut next week
Adaptive Biotechnologies - Seattle, 12.5 million shares, priced $15-$17, managed by Goldman Sachs/JP Morgan. Proposed Nasdaq symbol ADPT.
- Wyoming Business Council recommends $9.3M for Cheyenne plant
(AP) — The Wyoming Business Council board has recommended the state approve a $9.35 million loan for the construction of a biomedical ...